NorthRock Partners LLC Has $2.37 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

NorthRock Partners LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 209.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,535 shares of the medical equipment provider’s stock after purchasing an additional 3,070 shares during the period. NorthRock Partners LLC’s holdings in Intuitive Surgical were worth $2,367,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of ISRG. Vanguard Group Inc. lifted its position in shares of Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after buying an additional 360,591 shares during the last quarter. Geode Capital Management LLC boosted its position in Intuitive Surgical by 3.2% during the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock worth $4,039,200,000 after purchasing an additional 243,802 shares during the period. Fisher Asset Management LLC increased its holdings in shares of Intuitive Surgical by 1.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after purchasing an additional 86,488 shares during the last quarter. Norges Bank bought a new position in shares of Intuitive Surgical in the fourth quarter valued at about $2,401,493,000. Finally, Invesco Ltd. lifted its stake in shares of Intuitive Surgical by 7.7% during the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock worth $2,165,184,000 after buying an additional 295,025 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $563.95 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $379.67 and a fifty-two week high of $616.00. The company has a market cap of $202.13 billion, a PE ratio of 87.98, a P/E/G ratio of 5.85 and a beta of 1.70. The stock’s fifty day moving average price is $501.31 and its two-hundred day moving average price is $535.58.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period last year, the firm posted $1.50 earnings per share. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This represents a 60.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the sale, the vice president now directly owns 473 shares in the company, valued at $271,397.94. The trade was a 63.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 32,636 shares of company stock valued at $16,829,815. 0.70% of the stock is owned by insiders.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Royal Bank of Canada lowered their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a report on Wednesday, April 23rd. Erste Group Bank cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. JPMorgan Chase & Co. upped their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Raymond James lifted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Finally, BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a “buy” rating in a research note on Monday, April 14th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.